Lupin gets UK marketing authorisation for Luforbec 100/6 µg pMDI
Luforbec 100/6 µg pMDI is indicated for regular treatment of asthma and for the symptomatic treatment of patients with severe COPD
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.